title: Development of controlled release formulations by means of ALRISE's ImSus(®) platform technology.
authors.affiliation: ALRISE Biosystems GmbH, 13125 Berlin, Germany. seemann@alrise.de
authors.forename: H
authors.initials: H
authors.lastname: Seemann
authors.forename: C
authors.initials: C
authors.lastname: Albayrak
authors.forename: V
authors.initials: V
authors.lastname: Rindler
mesh_terms: D000818:Animals; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D051381:Rats; D012995:Solubility; D013678:Technology, Pharmaceutical / Q000379:methods*
chemical_list: D003692:Delayed-Action Preparations; D052216:Glucagon-Like Peptide 1